Univariate analysis | Multivariable analysis* | |
---|---|---|
HR (95% CI) | HR (95% CI) | |
No autoimmune diseases | Reference | Reference |
Autoimmune diseases | ||
RA | 1.32 (1.10–1.59) | 1.37 (1.13–1.66) |
SLE | 1.21 (0.95–1.54) | 1.41 (1.10–1.80) |
AS | 0.67 (0.37–1.21) | 0.88 (0.46–1.70) |
PSO/PSA | 1.36 (1.05–1.78) | 1.05 (0.80–1.38) |
Others | 1.17 (1.01–1.36) | 1.15 (0.99–1.34) |
*Adjusted for age, gender, cancer stage, prior use of biologic agents or tofacitinib, baseline hemoglobulin, creatinine, log (ALT) and log (WBC).